Preferable effects of pemafibrate on liver function and fibrosis in subjects with type 2 diabetes complicated with liver damage

BACKGROUND: Pemafibrate has been reported to ameliorate lipid profiles and liver dysfunction. However, which patients derive benefit from the hepatoprotective effects of pemafibrate is unclear. METHODS: We conducted a sub-analysis of the PARM-T2D study where subjects with type 2 diabetes complicated...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomoto, Hiroshi, Kito, Kenichi, Iesaka, Hiroshi, Handa, Takahisa, Yanagiya, Shingo, Miya, Aika, Kameda, Hiraku, Cho, Kyu Yong, Takeuchi, Jun, Nagai, So, Sakuma, Ichiro, Nakamura, Akinobu, Atsumi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601300/
https://www.ncbi.nlm.nih.gov/pubmed/37880780
http://dx.doi.org/10.1186/s13098-023-01187-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601300/
https://www.ncbi.nlm.nih.gov/pubmed/37880780
http://dx.doi.org/10.1186/s13098-023-01187-7

Ejemplares similares